Univest
Univest
  • Markets
  • SBI Long Term Advantage Fund – Series VI vs Sundaram Micro Cap Series V Regular IDCW Payout: NAV, Returns and Maturity Status Compared

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    SBI Long Term Advantage Fund - Series VI vs Sundaram Micro Cap Series V Regular IDCW Payout

    SBI Long Term Advantage Fund – Series VI vs Sundaram Micro Cap Series V Regular IDCW Payout: full NAV, returns and maturity status comparison based on official AMFI data.

    read more
  • UTI Long Term Advantage Fund Series IV vs Sundaram Micro Cap Series III Regular: NAV, Returns and Maturity Status Compared

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    UTI Long Term Advantage Fund Series IV vs Sundaram Micro Cap Series III Regular

    UTI Long Term Advantage Fund Series IV vs Sundaram Micro Cap Series III Regular: full NAV, returns and maturity status comparison based on official AMFI data.

    read more
  • BPCL Share Price Gains 0.62% to Rs 315.95 After Q1 Results

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    BPCL Share Price Gains

    BPCL share price gained 0.62% to Rs 315.95 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026. Q1 FY27 revenue stood at Rs 160776 crore.

    read more
  • Bhagwati Autocast Share Price Gains 20% to Rs 687.95 After Q1 Results

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Bhagwati Autocast Share Price Gains

    Bhagwati Autocast share price gained 20% to Rs 687.95 as of 23 July 2026, after the company announced its Q1 FY27 results on 21-22 July 2026. Full details, financials and o

    read more
  • SBI Long Term Advantage Fund – Series VI vs Bank of India Mid Cap Tax Fund Series 1 Regular IDCW: NAV, Returns and Maturity Status Compared

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    SBI Long Term Advantage Fund - Series VI vs Bank of India Mid Cap Tax Fund Series 1 Regular IDCW

    SBI Long Term Advantage Fund – Series VI vs Bank of India Mid Cap Tax Fund Series 1 Regular IDCW: full NAV, returns and maturity status comparison based on official AMFI data.

    read more
  • NTPC Green Energy Share Price Gains 7.11% to Rs 97.79 After Q1 Results

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    NTPC Green Energy Share Price Gains

    NTPC Green Energy share price gained 7.11% to Rs 97.79 as of 23 July 2026, after the company announced its Q1 FY27 results on 22 July 2026. Full details, financials and out

    read more
  • Sundaram Long Term Micro Cap Tax Advantage Fund Series III vs UTI Series VI: NAV, Returns and Maturity Status Compared

    • July 23, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Sundaram Long Term Micro Cap Tax Advantage Fund Series III vs UTI Series VI

    Sundaram Long Term Micro Cap Tax Advantage Fund Series III vs UTI Series VI: full NAV, returns and maturity status comparison based on official AMFI data.

    read more
  • Trishakti Industries Share Price Falls 3.29% to Rs 223.5 After Q1 Results

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Trishakti Industries Share Price Falls

    Trishakti Industries share price fell 3.29% to Rs 223.5 as of 23 July 2026, after the company announced its Q1 FY27 results on 21-22 July 2026. Full details, financials and

    read more
  • Torrent Pharmaceuticals vs Mankind Pharma Business Model: Which Domestic Branded Formulations Wins

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Torrent Pharmaceuticals vs Mankind Pharma Business Model

    Torrent Pharmaceuticals vs Mankind Pharma business model compares concentrated cardiac and CNS therapeutic branded formulations leadership against scale-led domestic branded generics combined with consumer healthcare products to see which domestic branded formulations has better business model.

    read more
  • Alembic vs JB Chemicals Business Model: Which Domestic Branded Formulations Wins

    • July 23, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Alembic vs JB Chemicals Business Model

    Alembic vs JB Chemicals business model compares diversified branded generics manufacturing across multiple therapeutic categories against concentrated cardiac and gastro-intestinal therapeutic branded formulations to see which domestic branded formulations has better business model.

    read more
  • 1
  • …
  • 1,268
  • 1,269
  • 1,270
  • 1,271
  • 1,272
  • …
  • 2,705